TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Cmax; peak plasma concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC; area under the concentration-time curve
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: bio-markers for therapy and prognosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CPSP at 6 months
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: Acute Rejection Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: amount of time participants spend in app
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: satisfaction with mindfulness coach survey
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Bakas Caregiver Outcomes Scale - 15 items
Endpoint domain: Life impact
Endpoint subdomain: Societal/carer burden
Primary endpoint: Presence of epilepsy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Proportion of patients guided wisely by imaging technique
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Biodistribution of Technetium Tc 99m EC20
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Excretion of Technetium Tc 99m EC20
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Radiation absorbed dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Immunogenicity of AVONEX®
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Sampling time for vancomycin concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sampling time for gentamycin concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants with Treatment Related Severe Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Change of vascular endothelial growth factor C
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Change of prostaglandin E2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Radiographic Assessment of Interproximal Carious lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in MRI LVEF
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in Kansas City Cardiomyopathy Questionnaire Answers
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Difference in precision in millimeter between CT scanners
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in bacterial profile of the sinuses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: AUC of the PI-RADS v2.1 score for predicting ISUP ≥2 cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Percentage of Participants Who Experience an Injection-site Adverse Event (AE)
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Participants With Body Temperature ≥100.0°F (≥37.8ºC)
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Participants Who Experience a Systemic AE
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Participants Who Experience a Serious Adverse Event (SAE) Within 15 Days of Any Vaccination
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Participants Who Experience a Vaccine-related SAE Any Time During Study
Endpoint domain: Adverse events/effects
Primary endpoint: Change from baseline shear wave elastography (SWE) at 8 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Change from baseline liver steatosis at 8 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Concentration of high-density lipoprotein (HDL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in serum Albumin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Functional Capacity and Mobility
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy of cholangioscopy in gallstone therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Efficacy of cholangioscopy in stricture diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Percent Signal Change in fMRI BOLD Signal
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Acute respiratory failure rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Dyspnea according to CTCAE v4.0
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Incidence and severity of bleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Patient Controlled Analgesia (PCA) use during delivery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Incidence of Serious Device- and Procedure-Related Complications
Endpoint domain: Adverse events/effects
Primary endpoint: Level of (in)dependence via the Katz scale
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Nutritional status via the Mini Nutritional Assessment (MNA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Weight loss via the evaluation of body weight
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percentage of Patients using Prescribed Medication
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Markers of neuronal damage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Percent change from baseline in the frequency of motor seizures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Children's Depression Rating Scale (CDRS-R)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical Global Impression - Bipolar Version (CGI)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: score on Harvard Trauma Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Impact of Event Scale Revised
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Discussion of guideline-appropriate contraceptive methods
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Mean oxygen saturation during sleep
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Capillary transit time heterogeneity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in K-TMT-e A of K-VCIHS-NP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: percentage of CD4+ and CD8+ T lymphocytes with activation markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Clinical competency
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: state negative emotions
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: state positive emotions
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: incidence of clinically important pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ILD prevalence
Endpoint domain: Mortality/survival
Primary endpoint: Neuro-developmental follow-up
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in Self-perceived stress scale score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: blood immune factors
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Collection of blood volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: euploidy rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Changes in Treatment Satisfaction Questionnaire for Medication
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in medical management
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Average MDASI-HNC Scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Duration of Vasopressors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Drug measurement of MPA, MPA-G and acyl-MPA-G
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Genotyping for UGT2B7, UGT1A8, UGT1A9 polymorphism
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fold Increase in ASM Proliferation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Composite complete rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline to Week 6 in 24 Hour Mean Diastolic Blood Pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change From Baseline to Week 6 in Trough Diastolic Blood Pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: number of days free of vasoactive support
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: recurrence of pneumothorax
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: complete lung inflation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: air leak assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Retention of Learning
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Pain Occurrence
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of negative appendectomies
Endpoint domain: Mortality/survival
Primary endpoint: Myocardial Creatine Kinase (CK) Flux
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Time until pain score less than or equal to 3
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Epithelization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Number of patients with abnormal cardiac rhythm detected
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of patients with confirmed Atrial Fibrillation (AF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mean change ambulatory blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Gastric precancerous detection rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change in HbA1c-level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: proportions of seroconversion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: proportions of seroprotection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Safety of the A H1N1 vaccine
Endpoint domain: Adverse events/effects
Primary endpoint: Occurrence of vaccine-associated unsolicited adverse events through Day 28 after the last vaccination
Endpoint domain: Adverse events/effects
Primary endpoint: Occurrence of vaccine-associated solicited local and systemic adverse events within 8 days post-vaccination (Day 0-7)
Endpoint domain: Adverse events/effects
Primary endpoint: Occurrence of vaccine-associated unsolicited serious adverse events (SAEs) through the course of the study
Endpoint domain: Adverse events/effects
Primary endpoint: Completion of LLTTF training by prison officers
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Completion of 4 appointments of LLTTF by prisoners
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Endothelial function measured by flow-mediated dilation (FMD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: number of lesions requiring ablation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Duration of sensory anesthesia and analgesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Disc height ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Segmental lordosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in flow mediated dilatation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in Plaque score %
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Calculus ratio %
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Free gingival margin color (CEILAB color space)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline in Quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Neural activity parameters of EEG
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Neural activity parameters of MRI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Neural activity parameters of near-infrared brain imaging
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Facial action parameters of facial expression recognition technology
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MicroRNA expression levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Pharmacokinetics of KADIAN
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Items Recalled
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in ratio of M2 versus M1 monocytes and macrophages
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Body Mass Index standard deviation score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in muscle size parameter
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in isometric muscle strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in functional muscle strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Change From Baseline in the IRLS Rating Scale Total Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With Clinically Meaningful Augmentation and Early Morning Rebound (EMR) Cases
Endpoint domain: Adverse events/effects
Primary endpoint: Leptin Receptor Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants Achieving Predefined Serotype-specific IgG Antibody Concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Serotype-specific Opsonophagocytic Activity (OPA) Geometric Mean Titers (GMTs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in Cellular Granular Osmiophilic Deposits (GRODs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Velocity in Gait
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cadence in Gait
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Speech Velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Speech Cadence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Addiction level
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: predictive value of multivariate prognostic models
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Incidents of wound infections
Endpoint domain: Adverse events/effects
Primary endpoint: Very Good Partial Response Rate (VGPR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall device success
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Russell's periodontal index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: plaque/gingival indices
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: modified gingival index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Endothelial Density
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 18F-clofarabine concentration in cancer tissue
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change in 18F-clofarabine biodistribution
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of acute and chronic GvHD
Endpoint domain: Adverse events/effects
Primary endpoint: Grade of acute and chronic GvHD
Endpoint domain: Adverse events/effects
Primary endpoint: Stage of acute and chronic GvHD
Endpoint domain: Adverse events/effects
Primary endpoint: ECG change in QTcF
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Occurrence of intradialytic hypotensive episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Indoor Tanning Behavior
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Indoor Tanning Intentions
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Indoor Tanning Willingness
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Parker Mobility Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postel Merle d'Aubigné score (PMA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of time of use of the BeatHealth device
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: change in disease severity scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Progression of fasting glucose >140 mg/dL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change from Baseline PPE Grade
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in the Patient-Rated Tennis Elbow Evaluation score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Number of patients with abnormal laboratory studies
Endpoint domain: Adverse events/effects
Primary endpoint: Bi-parietal diameter
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Retention rates of prefabricated and resin composite veneers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Early Ambulation
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Safety and tolerability of PfSPZ Vaccine
Endpoint domain: Adverse events/effects
Primary endpoint: Treatment accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Identification of HCC biomarkers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of fistula closure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Long-term Cognitive Impairment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Patient response to treatment with Adalimumab
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall Safety Profile
Endpoint domain: Adverse events/effects
Primary endpoint: Differences in circulating biomarkers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in human gut microbiota
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Tear cytokines levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Rate of change in high risk groups compared to controls
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline in Mean Systolic Blood Pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in the Cornell Scale for Depression in Dementia (CSDD)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in duration of nocturnal sleep time
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Clinical Cure at Day 4 (EOT)/Exit Visit
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: survival rate of severe sepsis patients
Endpoint domain: Mortality/survival
Primary endpoint: Rate of patients achieving improvement in clinical condition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cathelicidin mRNA Expression Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Change in diabetes knowledge
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning